Dyfodol and RCPsych in Wales - National Psychosis Conference 2026

The innovative Dyfodol (meaning 'Future') programme offers several workstreams to both respond to challenges and opportunities across the health service, but also to model and design future services and pathways. This is achieved through an evidence-based, and informed approach, and through research collaborations with partners.

The programme is hosted within the National Collaborating Centre for Mental Health (NCCMH), and works in partnership with RCPsych in Wales and the NHS Wales Joint Commissioning Committee (JCC). It's received funding, and reports to Welsh Government on commissioned work.

This National Psychosis Conference will mark a formal launch of the Dyfodol programme, whilst the programme has also helped subsidise the registration cost for delegates.

Further information on Dyfodol is available.

Since last year's RCPsych International Congress, which was held in Newport; RCPsych in Wales has been celebrating its 20 year anniversary with a range of activities and events.

You can read more detail on the unique artwork of Rhiannon Roberts, which was commissioned to mark this milestone.

We have a number of bursaries for medical students who wish to attend this conference.

Please complete the linked form and we'll be in touch.

We are inviting delegates to be part of the programme by displaying an academic poster, whilst we have also a number of opportunities for oral presentations during our rapid-fire presentation session. This could involve an audit, research, or a general project.

Please note that, unfortunately, we cannot offer a free place at the conference for presenters. However the conference is heavily subsidised.

Poster prizes will be awarded, and please note that posters can be submitted that aren't specifically related to Psychosis. However, we will have an additional award category for Psychosis related posters.

If you would like to be considered, please read our Call for Abstracts and send your Abstract to Ollie John by 1pm on Thursday 9 April 2026. All who submitted an abstract will be informed of the outcome on Friday 10 April.

We are delighted to introduce several of our speakers and sessions.

Kate Northcott Spall, Campaigner and co-author of the WIMS Protocol, Prof Sir Robin Murray, Professor of Psychiatric Research, Kings College London, and Dr Ashley Liew, Paediatric Neuropsychiatrist at South London and Maudsley NHS Foundation Trust, and the subjects that they will be presenting.

Prof Murray will be presenting on 'An aetiological approach to the treatment of psychosis', Dr Liew on 'Challenging Cartesian Dualism: Neurological conditions presenting as Psychosis in Children', whilst Kate will be talking about her campaigning work, including the most recent work in development of the WIMS protocol for safe monitoring of clozapine.

We'll be hearing from Dr Hamilton Morrin, Neuropsychiatrist at South London & Maudsley NHS Foundation Trust, on AI & Psychosis; Dr Sally Wilson, National Training Coordinator at Action on Postpartum Psychosis (APP); and Dr Ed Beveridge, Presidential Lead for Physical Health at the Royal College of Psychiatrists.

We'll also be hosting presentations from Dr Kim Kendall, All-Wales Psychiatric Genomic Service; Prof Helen Killaspy, Professor of Rehabilitation Psychiatry at University College London; and Prof Pamela Taylor CBE, Professor of Forensic Psychiatry at Cardiff University.

Additionally, Prof Alka Ahuja, Chair of the Royal College of Psychiatrists Wales; and Ollie John, Head of Dyfodol, will be talking about the work of the Dyfodol programme.